Onco Wiki / Doença

Pineoblastoma

Visão determinística da entidade fonte YAML. A autoridade clínica permanece com os IDs de fonte citados e estado de assinatura do revisor.

IDDIS-PINEOBLASTOMA
TipoDoença
Alegais
Pineoblastoma associado ao DICER1PNET da região pinealTumor embrionário pinealПінеобластома
Estadoreviewed 2026-05-20 | pending_clinical_signoff
DoençasNenhuma declaração
FontesSRC-COG SRC-NCCN-CNS-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Fonte YAML

icd_o_3_morphology9362/3
icd_o_3_topography["C75.3"]
icd_10C75.3
who_classificationWHO CNS Tumours 5th ed (2021): Pineoblastoma (Grade 4 embryonal CNS tumour); molecular subtypes include DICER1-altered, miRNA-processing-altered, MYC/FOXR2-activated, and RB1-altered groups

Capacidades

Notas

Pineoblastoma is one of the canonical embryonal CNS manifestations of DICER1 syndrome — diagnosis in any child should trigger DICER1 germline testing regardless of family history. Distinct from pineocytoma (Grade 1, benign) and pineal parenchymal tumour of intermediate differentiation (PPTID, Grade 2-3). Treatment philosophy parallels other embryonal CNS tumours: maximal safe surgical resection (gross total resection is prognostically dominant); craniospinal irradiation in age-appropriate patients (deferred under age 3 due to neurocognitive toll); adjuvant high-dose chemotherapy regimens (often COG/SIOP protocols with carboplatin, vincristine, cyclophosphamide, cisplatin, etoposide combinations + autologous stem-cell rescue in high-risk cases). Trilateral retinoblastoma (bilateral RB1-carrier with pineal pineoblastoma) historically had near-uniform mortality; modern MRI surveillance from RB1-carrier diagnosis has shifted some cases to earlier detection with improved outcomes.

Usado por

Doença